About Us
Our Partnership
Key Structures
Engage With Us
Topics
Replenishment
Our Financing
Results & Data
Impact Stories
The “Pink Girls” of Zambia: Breaking Down HIV Silence and Stigma
An Invisible Line of Defense: How Laboratory Workers in Asia-Pacific Protect Against the Next Pandemic
Global Health Security
A Decade of Progress: Halting Drug-Resistant Malaria in Southeast Asia
Media Resources
News Releases
Opinion
Publication Categories
Resources
18 February 2022
The U.S. Food and Drug Administration (FDA) has recently published a safety communication on Pulse Oximeter Accuracy and Limitations.
While the COVID-19 pandemic has caused an increase in the use of pulse oximeters, a recent report (Sjoding et al.) suggests that the devices may be less accurate in people with dark skin pigmentation.
The US FDA communication recalls that although pulse oximetry is useful for estimating blood oxygen levels, pulse oximeters have limitations and a risk of inaccuracy under certain circumstances that should be considered.